Advances in bispecific biotherapeutics for the treatment of cancer.

@article{May2012AdvancesIB,
  title={Advances in bispecific biotherapeutics for the treatment of cancer.},
  author={Chad May and Puja Sapra and H. G. Gerber},
  journal={Biochemical pharmacology},
  year={2012},
  volume={84 9},
  pages={1105-12}
}
Conventional monoclonal antibody (mAb) therapeutics interfering with cellular signaling of their respective target antigens are frequently limited in their ability to induce significant anti-tumor activities when administered as single agents in patients with solid tumors. To overcome these limitations, several new technologies are being developed to empower biotherapeutics and to improve their anti-tumor activities, while maintaining their high tumor selectivity and superior safety profiles… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
30 Extracted Citations
0 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 30 extracted citations

Similar Papers

Loading similar papers…